Abstract
Neural precursors that are found in the subventricular zone and dentate gyrus of the adult brain might be useful in cell replacement therapies for neurological disorders. The development of pharmacological drugs that would increase production of new neurons would be facilitated by identification of the endogenous or natural molecular regulators of adult neurogenesis in vivo. This review discusses known endogenous regulators of the cellular events that are required for functional neurogenesis in adult animals. These steps include proliferation of stem cells and progenitors, survival and migration of new neuroblasts, differentiation into mature neurons and functional integration into existing neural circuits. Various treatments have been shown to enhance neurogenesis and neuroblast migration in adult rodents, raising the possibility that these resident neural stem cells could be used to treat people with neurological disorders. This review also highlights some of the potential problems and limitations that may arise when considering such therapies.
Keywords: Dentate gyrus, growth factor, integrin, migration, neural stem cell, neurodegenerative, subventricular, transmitter
Current Pharmaceutical Design
Title: Endogenous Regulators of Adult CNS Neurogenesis
Volume: 13 Issue: 18
Author(s): Theo Hagg
Affiliation:
Keywords: Dentate gyrus, growth factor, integrin, migration, neural stem cell, neurodegenerative, subventricular, transmitter
Abstract: Neural precursors that are found in the subventricular zone and dentate gyrus of the adult brain might be useful in cell replacement therapies for neurological disorders. The development of pharmacological drugs that would increase production of new neurons would be facilitated by identification of the endogenous or natural molecular regulators of adult neurogenesis in vivo. This review discusses known endogenous regulators of the cellular events that are required for functional neurogenesis in adult animals. These steps include proliferation of stem cells and progenitors, survival and migration of new neuroblasts, differentiation into mature neurons and functional integration into existing neural circuits. Various treatments have been shown to enhance neurogenesis and neuroblast migration in adult rodents, raising the possibility that these resident neural stem cells could be used to treat people with neurological disorders. This review also highlights some of the potential problems and limitations that may arise when considering such therapies.
Export Options
About this article
Cite this article as:
Theo Hagg , Endogenous Regulators of Adult CNS Neurogenesis, Current Pharmaceutical Design 2007; 13 (18) . https://dx.doi.org/10.2174/138161207780858393
DOI https://dx.doi.org/10.2174/138161207780858393 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Emerging Strategies to Strengthen the Anti-Tumour Activity of Type I Interferons: Overcoming Survival Pathways
Current Cancer Drug Targets The Use of Anthracyclines for Therapy of CNS Tumors
Anti-Cancer Agents in Medicinal Chemistry DNA Methylation: A Possible Target for Current and Future Studies on Cancer?
Epigenetic Diagnosis & Therapy (Discontinued) Structural Features of the Interleukin-10 Family of Cytokines
Current Pharmaceutical Design Proteomic Analysis of Glioma Chemoresistance
Current Neuropharmacology Clinical Approaches Toward Tumor Angiogenesis: Past, Present and Future
Current Pharmaceutical Design Xanthone Derivatives: New Insights in Biological Activities
Current Medicinal Chemistry Aquaporins and Glia
Current Neuropharmacology A Common Pathway for All Autoimmune Diseases? The Unholy Alliance of Environment, Cell Death and Nucleic Acids
Current Immunology Reviews (Discontinued) Peptides Targeting Gap Junctional Structures
Current Pharmaceutical Design The Complexities of TGF-β Action During Mammary and Squamous Cell Carcinogenesis
Current Pharmaceutical Biotechnology Efficacy and Safety of Bevacizumab in Glioblastomas
Current Medicinal Chemistry Tumor Vasculature Targeting Through NGR Peptide-Based Drug Delivery Systems
Current Pharmaceutical Biotechnology The PIK3CA Gene as a Mutated Target for Cancer Therapy
Current Cancer Drug Targets Structure and Ligand Based Drug Design Strategies in the Development of Novel 5- LOX Inhibitors
Current Medicinal Chemistry Cyclooxygenase-2: Potential Role in Regulation of Drug Efflux and Multidrug Resistance Phenotype
Current Pharmaceutical Design Therapeutic Perspectives of Inhibitors of Endocannabinoid Degradation
Current Drug Targets - CNS & Neurological Disorders Nitric Oxide: Target for Therapeutic Strategies in Alzheimers Disease
Current Pharmaceutical Design IL-13 and its Signal Pathway: Promising Targets in the Development of a Therapeutic Agent for Bronchial Asthma
Current Signal Transduction Therapy Mitochondrial Physiology and Toxicity (Mitotoxicity); Importance for the Immune System, Programmed Cell Death and Cancer
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents